Market Dashboard
- You are here:
- Home
- Markets
- Market Dashboard
- Neuland Laboratories Ltd.
NSE Symbol: | BSE Code: | ISIN: | Sector:
- Add to Portfolio
- Add to Watchlist
- Add to Alert
- Add to Message
Add to Portfolio
NSE
5175.05
| Change | Change % |
| -39.55 | -0.76% |
Updated:30 Nov, 2023, 09:34 AM IST |
|
BSE
5194.75
| Change | Change % |
| -22.85 | -0.44% |
Updated:30 Nov, 2023, 09:45 AM IST |
|
Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)
Day's Range
5137.755214.90
52 Wk Range
431.45 5214.90
Compare Price performance of vs. Peer Companies
From sector
Compare with Peers on Key Fundamentals and Financials
- SUNPHARMA
1.50% - DIVISLAB
0.28% - CIPLA
0.60% - DRREDDY
1.58% - CADILAHC
1.13% - AUROPHARMA
1.80% - LUPIN
1.15% - ALKEM
0.50% - ABBOTINDIA
-0.24% - TORNTPHARM
0.99% - BIOCON
1.76% - GLAXO
1.02% - GLENMARK
0.62% - SANOFI
0.30% - PFIZER
-0.56% - PEL
2.02% - AJANTPHARM
1.82% - APLLTD
11.02% - NATCOPHARM
1.47% - IPCALAB
2.03% - ERIS
0.49% - ASTRAZEN
-0.53% - JBCHEPHARM
4.57% - GRANULES
5.57% - CAPLINLABS
0.43% - MERCK
-1.25% - FDC
-0.03% - NEULANDLAB
-0.44% - MARKSANS
10.85% - STAR
-1.23%
's Latest Research Report
| Brokerage/Analyst | Report Date | Call | Price@Call | Target | Current Status | Report |
|---|---|---|---|---|---|---|
| Anand Rathi - |
13-02-2020 | Buy | 462.80 | 644.00 | Closed | Details |
Neuland Laboratories's Key Fundamentals
| Parameter | Values |
|---|---|
| Market Cap (in ₹ Cr.) | 6,639.54 |
| Earning Per Share (EPS TTM) (₹) | 15.70 |
| Price To Earnings (P/E) Ratio | 329.62 |
| Book Value Per Share (₹) | 541.45 |
| Price To Books (P/B) Ratio | 9.56 |
| EBIT Margin (%) | 5.32 |
| PAT Margin (%) | 2.42 |
| ROCE (%) | 3.95 |
| PAT Growth (%) | 36.71 |
| Total Debt to Equity (D/E) Ratio | 0.33 |
More from Key Fundamentals »
Neuland Laboratories's Financial Summary
| Parameter | MAR'19 (₹ Cr.) |
MAR'18 (₹ Cr.) |
YoY %Change |
|---|---|---|---|
| Balance Sheet: | |||
| Share Capital | 12.90 | 8.95 | 44.06% |
| Total Non-Current Liabilities | 103.13 | 145.78 | -29.26% |
| Total Current Liabilities | 331.19 | 370.38 | -10.58% |
| Total Liabilities | 1,129.90 | 1,070.94 | 5.50% |
| Total Non-Current Assets | 676.96 | 624.22 | 8.45% |
| Currents Investments | 7.50 | 7.50 | 0.00% |
| Cash and Bank | 37.35 | 17.05 | 119.02% |
| Total Current Assets Excluding Current Investments | 445.43 | 439.23 | 1.41% |
| Total Assets | 1,129.90 | 1,070.94 | 5.50% |
| Profit and Loss: | |||
| Gross Sales | 666.83 | 529.16 | 26.02% |
| Net Sales | 666.83 | 527.41 | 26.44% |
| PBIDT (Excl OI) | 57.87 | 50.03 | 15.66% |
| PAT | 16.14 | 11.81 | 36.71% |
More from Financial Summary »
Neuland Laboratories's Shareholding Pattern
| Description | Percent of Share (%) |
|---|---|
| Promoters | 38.43 |
| Individuals | 31.18 |
| Institutions | 0.01 |
| FII | 1.82 |
| Govt. | 0.00 |
| Others | 28.56 |
More from Holding Pattern »
Neuland Laboratories held by Mutual Fund Schemes
| Scheme | Holding(%) | |
|---|---|---|
| SBI Healthcare Opportunities Fund Regular Plan Dividend | 1.66 |
|
| ICICI Prudential Pharma Healthcare and Diagnostics (PHD) Fund Growth | 1.01 |
|
More from Mutual Fund Holding »
..